Introduction

MDI Considerations for Prescription Drug Monitoring Programs

MDI Considerations for Prescription Drug Monitoring Programs

← Back to MDI Webinar Series

This webinar originally occurred on November 4, 2021
Duration: 1 hour

Overview

Medical examiners and coroners use a variety of data sources to complete a medicolegal death investigation (MDI) and make determinations on a cause and manner of death. One of those data sources is state prescription drug monitoring programs (PDMPs). PDMPs are state-operated databases and medicolegal surveillance systems that document the dispensing of certain prescription medications to individual patients. Typically, PDMPs aggregate transactional records of controlled substance prescriptions when dispensed in outpatient pharmacy settings. This means that a patient receives the medication for in-home use rather than being administered the medication directly by a healthcare provider within a medical facility, such as a hospital or clinic. This information can provide critical details on a patient’s history of treatment for substance use disorder, predicted opioid tolerance, prescribers/dispensers of last contact, unusual drug utilization patterns, and other investigative clues.

Also, medical examiners'/coroners' (ME/C's) use of PDMPs may itself be an area of new research. For example, how much time does an ME/C save during an investigation by using PDMP data? Can tools specific to the ME/C community be developed by PDMPs? Does tracking ME/C's use of the PDMPs provide any insight or value to understanding the substance use epidemic? The answers to these questions could provide valuable information to the MDI community and other stakeholders.

Detailed Learning Objectives

  1. Attendees will be able to identify how ME/Cs use PDMP data for a medicolegal death investigation.
  2. Attendees will be able to understand how ME/Cs access PDMPs, how access of PDMPs is tracked in state databases, and what methods exist for quantifying measures of use.
  3. Attendees will gain awareness of new opportunities and barriers for research on ME/C's use of PDMPs.

Presenter

  • Chris Delcher, Ph.D. | Epidemiologist and Associate Professor in the Department of Pharmacy Practice and Science & Director of the Institute for Pharmaceutical Outcomes and Policy at the University of Kentucky

Funding for this Forensic Technology Center of Excellence webinar has been provided by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice.

The opinions, findings, and conclusions or recommendations expressed in this webinar are those of the presenter(s) and do not necessarily reflect those of the U.S. Department of Justice.

Contact us at ForensicCOE@rti.org with any questions and subscribe to our newsletter for notifications.


Related Content

Evaluation of Purdue University’s 3D Imaging Prototype for Footwear and Tire Impressions

Date September 2022 Overview Supported by two National Institute of Justice (NIJ) awards (2016-DN-BX-0189 and 2019-R2-CX-0069), Dr. Song Zhang and his research team at Purdue University led the development of a fully automated 3D imaging system for footwear and tire…

FLN-TWG: Updating Data Collection for Digital Evidence Casework in Project FORESIGHT

← Back to FLN-TWG Main Page  Forensic Laboratory Needs Technology Working Group (FLN-TWG) The National Institute of Justice (NIJ), in partnership with the Forensic Technology Center of Excellence (FTCOE) at RTI International, formed the Forensic Laboratory Needs Technology Working Group…

Guidance Document on Considerations for Photographic Documentation in Sexual Assault Cases

Date August 2022 Overview Sexual Assault Nurse Examiners (SANEs) are medical professionals with specialized training and expertise in medicine, psychology, and forensic science and are qualified to conduct sexual assault forensic examinations. During the sexual assault forensic examination, SANEs may…